Tilray, Inc. TLRY shares are trading lower amid profit-taking after the stock rallied yesterday following the company's second-quarter earnings results.
The company's stock rallied about 30% higher yesterday after announcing financial results that were significantly higher year-over-year.
Tilray is a Canadian cannabis company that cultivates and sells medical and recreational cannabis. In May, Aphria and Tilray completed a reverse merger in which the new company was named Tilray.
Tilray's stock was trading about 3.75% lower at $15.41 per share on Thursday. The stock has a 52-week high of $67 and a 52-week low of $4.41.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
